Resultados da busca - Jesus-Maria Hernandez-Rivas

Mepolizumab for hypereosinophilic syndrome: effectiveness and safety from real-world evidence por Elvira Mora, María Laura Fox, María Laura Fox, Angelina Lemes, Beatriz Velasco, Jesús María Hernández-Rivas, Jesús María Hernández-Rivas

Obter o texto integral

Molecular profiling of pre- and post- 5-azacytidine myelodysplastic syndrome samples identifies predictors of response por Mónica del Rey González, Mónica del Rey González, Sohini Chakraborty, Jesús María Hernández-Sánchez, María Diez Campelo, Christopher Y. Park, Jesús María Hernández Rivas, Jesús María Hernández Rivas

Obter o texto integral

<i>ETV6</i>/<i>RUNX1</i> Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia por Adrián Montaño, Jose Luis Ordoñez, Verónica Alonso-Pérez, Jesús Hernández-Sánchez, Sandra Santos, Teresa González, Rocío Benito, Ignacio García-Tuñón, Jesús María Hernández-Rivas

Obter o texto integral

The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment por Claudia Pérez-Carretero, Isabel González-Gascón-y-Marín, Ana E. Rodríguez-Vicente, Miguel Quijada-Álamo, José-Ángel Hernández-Rivas, María Hernández-Sánchez, Jesús María Hernández-Rivas

Obter o texto integral

NEMHESYS—European Perspective on the Implementation of Next-generation Sequencing Into Clinical Diagnostics por Inmaculada Serramito-Gómez, Kathryn M. Clarke, Ana Eugenia Rodríguez-Vicente, Julie E. McGimpsey, María Abáigar, Carlos Barranquero Díez, Rocío Benito, Lars Bullinger, Ken I. Mills, Jesús María Hernández Rivas

Obter o texto integral

Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMD por Marta Fonseca-Santos, Marta Fonseca-Santos, Marta Fonseca-Santos, Marta Fonseca-Santos, Marta Fonseca-Santos, Borja Puertas, Borja Puertas, Borja Puertas, Borja Puertas, Borja Puertas, Javier Arzuaga-Méndez, Javier Arzuaga-Méndez, Idoya Ancin-Arteaga, Idoya Ancin-Arteaga, Sandra Castaño-Diez, Sandra Castaño-Diez, Carlos De Miguel, Carlos De Miguel, Marta Canet-Maldonado, Marta Canet-Maldonado, Marc Bosch-Schips, Marc Bosch-Schips, Pablo Palomo-Rumschisky, Pablo Palomo-Rumschisky, María Laura Blanco, María Laura Blanco, Daniel Gil-Alós, Daniel Gil-Alós, María Moreno-Igoa, María Moreno-Igoa, Pedro G. Santa-Catalina, Raúl Azibeiro, Raúl Azibeiro, Raúl Azibeiro, Raúl Azibeiro, Raúl Azibeiro, Carlos Puerta, Carlos Puerta, Carlos Puerta, Carlos Puerta, Carlos Puerta, Alba Mesa-Tudela, Alba Mesa-Tudela, Felix López-Cadenas, Felix López-Cadenas, Esperanza Tuset, Esperanza Tuset, Dolly Viviana Fiallo-Suarez, Dolly Viviana Fiallo-Suarez, Fernando Ramos, Fernando Ramos, Maria Teresa Gimenez, Maria Teresa Gimenez, Valeria Peri, Valeria Peri, Karan Mayani, Karan Mayani, M. Ángeles Montañes-García, M. Ángeles Montañes-García, Ana Villalba, Ana Villalba, Jesus María Hernandez Rivas, Jesus María Hernandez Rivas, Jesus María Hernandez Rivas, Jesus María Hernandez Rivas, Jesus María Hernandez Rivas, Jesus María Hernandez Rivas, Marina Díaz-Beyá, Marina Díaz-Beyá, María Díez-Campelo, María Díez-Campelo, María Díez-Campelo, María Díez-Campelo, María Díez-Campelo, María Díez-Campelo

Obter o texto integral

Examining the Effects of the RUNX1 p.Leu43Ser Variant on FPD/AML Phenotypes Using a CRISPR/Cas9-Generated Knock-In Murine Model por Ana Marin-Quilez, Ignacio García-Tuñón, Rocío Benito, José Luis Ordoñez, Lorena Díaz-Ajenjo, Ana Lama-Villanueva, Carmen Guerrero, Jesús Pérez-Losada, José Ramón González-Porras, Jesús María Hernández-Rivas, Mónica del Rey, José María Bastida

Obter o texto integral

SAMHD1 dysfunction impairs DNA damage response and increases sensitivity to PARP inhibition in chronic lymphocytic leukemia por Alberto Rodríguez-Sánchez, Miguel Quijada-Álamo, Claudia Pérez-Carretero, Ana B. Herrero, Andrés Arroyo-Barea, Julio Dávila-Valls, Araceli Rubio, Alfonso García de Coca, Rocío Benito-Sánchez, Ana E. Rodríguez-Vicente, Jesús María Hernández-Rivas, María Hernández-Sánchez

Obter o texto integral

Identification of two novel mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with bleeding diathesis por Teresa Sevivas, José María Bastida, David S. Paul, Eva Caparros, Verónica Palma-Barqueros, Margarida Coucelo, Dalila Marques, Francisca Ferrer-Marín, José Ramón González-Porras, Vicente Vicente, Jesús María Hernández-Rivas, Steve P. Watson, María Luisa Lozano, Wolfgang Bergmeier, José Rivera

Obter o texto integral

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group por Albert Oriol, Susana Vives, Jesús-María Hernández-Rivas, Mar Tormo, Inmaculada Heras, Concepción Rivas, Concepción Bethencourt, Federico Moscardó, Javier Bueno, Carlos Grande, Eloy del Potro, Ramon Guardia, Salut Brunet, Juan Bergua, Teresa Bernal, Maria-José Moreno, Carlota Calvo, Pilar Bastida, Evarist Feliu, Josep-Maria Ribera

Obter o texto integral

Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in onco-hematology. por Daniele Dall'Olio, Eric Sträng, Amin T Turki, Jesse M Tettero, Martje Barbus, Renate Schulze-Rath, Javier Martinez Elicegui, Tommaso Matteuzzi, Alessandra Merlotti, Luciana Carota, Claudia Sala, Matteo G Della Porta, Enrico Giampieri, Jesús María Hernández-Rivas, Lars Bullinger, Gastone Castellani, with the HARMONY Healthcare Alliance Consortium

Obter o texto integral

Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma por Nicola Gökbuget, Christina-Maria Hartog, Renato Bassan, Heinz-Gerd Derigs, Herve Dombret, Richard Greil, Jesus-Maria Hernández-Rivas, Francoise Huguet, Tamara Intermesoli, Eric Jourdan, Christian Junghanss, Lothar Leimer, Maria-Jose Moreno, Albrecht Reichle, Josep Ribera, Matthias Schmid, Hubert Serve, Matthias Stelljes, Reingard Stuhlmann, Dieter Hoelzer

Obter o texto integral

Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies por Lucía López-Corral, Luis Antonio Corchete, María Eugenia Sarasquete, María Victoria Mateos, Ramón García-Sanz, Encarna Fermiñán, Juan-José Lahuerta, Joan Bladé, Albert Oriol, Ana Isabel Teruel, María Luz Martino, José Hernández, Jesús María Hernández-Rivas, Francisco Javier Burguillo, Jesús F. San Miguel, Norma C. Gutiérrez

Obter o texto integral

Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes por Juan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Feiyang Ma, Kelly Chien, Monica Del Rey, Sanam Loghavi, Guillermo Montalban-Bravo, Vera Adema, Bethany Wildeman, Rashmi Kanagal-Shamanna, Alexandre Bazinet, Helen T. Chifotides, Natthakan Thongon, Xavier Calvo, Jesús María Hernández-Rivas, Maria Díez-Campelo, Guillermo Garcia-Manero, Simona Colla

Obter o texto integral

Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes por Juan Carlos Caballero, Julio Dávila, María López-Pavía, Esperanza Such, Teresa Bernal, Fernando Ramos, Marisa Calabuig, Jesús María Hernández Sánchez, Helena Pomares, Mercedes Sánchez Barba, María Abáigar, Bernardo González, Brayan Merchán, Reyes Sancho-Tello, Marta Callejas, Carolina Muñoz-Novas, Carlos Cerveró, Guillermo Sanz, Jesús María Hernández Rivas, María Díez Campelo;

Obter o texto integral

Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases por Victoria del Pozo, Irina Bobolea, Manuel J. Rial, Manuel J. Rial, Georgina Espigol-Frigolé, Roser Solans Laqué, Jesús María Hernández-Rivas, Elvira Mora, Astrid Crespo-Lessmann, José Luis Izquierdo Alonso, José Luis Izquierdo Alonso, María Sandra Domínguez Sosa, Juan Maza-Solano, Belén Atienza-Mateo, David Bañas-Conejero, Abraham L. Moure, Íñigo Rúa-Figueroa

Obter o texto integral

S213: BMS-986158, A POTENT BET INHIBITOR, AS MONOTHERAPY AND IN COMBINATION WITH RUXOLITINIB OR FEDRATINIB IN INTERMEDIATE- OR HIGH-RISK MYELOFIBROSIS (MF): RESULTS FROM A PHASE 1/... por Rosa Ayala, Nieves Lopez, Adi Shacham Abulafia, Maan Alwan, Costas K. Yannakou, Indu Raman, Vincent Ribrag, Chun Yew Fong, Yulia Volchek, Massimiliano Bonifacio, Alessandra Tucci, Jean-Jacques Kiladjian, Jésus Marïa Hernandez Rivas, Blanca Xicoy, Haifa Kathrin Al-Ali, Jean-Christope Ianotto, Si Tuen Lee-Hoeflich, Sharmilla Das, Bin Wu, Palanikumar Ravindran, Qian Zhao, Guan Wang, Oriana Esposito, Yu Liu, Zariana Nikolova, Christopher Tehlirian, Shodeinde Coker, David Lavie

Obter o texto integral

Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial por Josep-Maria Ribera, Mireia Morgades, Olga Garcia-Calduch, Maialen Sirvent, Buenaventura Buendia, Marta Cervera, Hugo Luzardo, Jesus-Maria Hernandez-Rivas, Marta Sitges, Irene Garcia-Cadenas, Pau Abrisqueta, Pau Montesinos, Mariana Bastos-Oreiro, Maria-Paz Queipo de Llano, Pilar Bravo, Anna Torrent, Pilar Herrera, Antoni Garcia-Guinon, Ferran Vall-llovera, Josefina Serrano, Maria-Jose Terol, Juan-Miguel Bergua, Ana Garcia-Noblejas, Cristina Barrenetxea, Laura Llorente, Daniel Garcia-Belmonte, Eva Gimeno, Antonia Cladera, Santiago Mercadal, Juan-Manuel Sancho

Obter o texto integral

Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols por Pere Barba, Mireia Morgades, Pau Montesinos, Jose Gonzalez-Campos, Anna Torrent, Cristina Gil, Teresa Bernal, Mar Tormo, Santiago Mercadal, Sandra Novoa, Irene García-Cadenas, M. Paz Queipo de Llano, Marta Cervera, Rosa Coll, Arancha Bermudez, M. Luz Amigo, Silvia Monsalvo, Jordi Esteve, Raimundo Garcia-Boyero, Andres Novo, Jesús Maria Hernandez Rivas, Antonia Cladera, Pilar Martinez-Sanchez, Josefina Serrano, Maria Teresa Artola, Beatriz Soria, Eugenia Abella, Ferran Vall-Llovera, Juan Bergua, Pilar Herrera, Daniel Barrios, Josep Maria Ribera, on behalf of the Spanish PETHEMA Group

Obter o texto integral

Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project por Irene Serrano-Gonzalo, Laura López de Frutos, Carlos Lahoz-Gil, Francisco Delgado-Mateos, María Ángeles Fernández-Galán, Montserrat Morales-Conejo, María Victoria Calle-Gordo, Daiana Ibarretxe-Gerediaga, Andrés Madinaveitia-Ochoa, Antonio Albarracin-Arraigosa, José Balanzat-Muñoz, Patricia Correcher-Medina, Luis Javier García-Frade, Jesús María Hernández-Rivas, Francesca Labbadia, Jesus Miguel López-Dupla, María Luisa Lozano-Almela, Elvira Mora-Casterá, María Soledad Noya-Pereira, María Ángeles Ruíz-Guinaldo, María del Mar Tormo-Díaz, Isidro Vitoria-Miñana, Isidro Arévalo-Vargas, Marcio Andrade-Campos, Pilar Giraldo

Obter o texto integral